| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/23/2003 | EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 07/23/2003 | EP1328631A2 Her-2/neu fusion proteins |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328542A1 Von willebrand factor-binding proteins from staphylococci |
| 07/23/2003 | EP1328293A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 07/23/2003 | EP1328287A1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2003 | EP1328286A1 Bone health compositions derived from milk |
| 07/23/2003 | EP1328284A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 07/23/2003 | EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 07/23/2003 | EP1077717B1 Use of lipopeptides or lipoproteins for wound treatment |
| 07/23/2003 | EP1073445B1 Substance mixture for topical application comprising olive oil and honey |
| 07/23/2003 | EP0920323B1 Novel use of phospholipids of animal origin in therapy and/or dietetics |
| 07/23/2003 | EP0914166B1 Methods of terminal sterilization of biological products |
| 07/23/2003 | EP0871476B1 Dried blood factor composition comprising trehalose |
| 07/23/2003 | EP0670905B1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 07/23/2003 | CN1432067A Sperm-DNA complexes for genetically modifying non-human animals |
| 07/23/2003 | CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns. |
| 07/23/2003 | CN1431008A Medicine for treating various fungal skin disease or bromidrosis |
| 07/23/2003 | CN1431003A Medicine for curing cerebral concussion and injuries from falls |
| 07/23/2003 | CN1430998A Drip pills for curing aphtha and its preparing method |
| 07/23/2003 | CN1430995A Formula for removing speckles as well as its preparing method |
| 07/23/2003 | CN1430989A Ointment of Chinese herbal medicine for reactivating nerve and its mfg. method |
| 07/23/2003 | CN1430982A Capsule of astragalus and honey as well as its preparing technique |
| 07/23/2003 | CN1430975A Extractive of ocean star worm, its preparing method and application |
| 07/23/2003 | CN1430974A Musk capsule for anti-thrombus |
| 07/23/2003 | CN1430973A Extractive of ÔÇÿJiaoyanÔÇÖ (Diamond fish or scientific name Mobula diabolus) possessing function of immunoloregulation, its preparing method and application |
| 07/23/2003 | CN1430972A Powder prepared from snake tissues for dipping in feet |
| 07/23/2003 | CN1430971A Method for lixiviating effective constituent of pilose antler in low temp. and ultrasonic cracking |
| 07/23/2003 | CN1115410C Process for preparing Mg-enriched spirulina |
| 07/23/2003 | CN1115165C Externally applied medicated wine for treating traumatic injury and rheumatism |
| 07/23/2003 | CN1115162C Pure traditional Chinese preparation for treating hyperosteogeny and prepn. process thereof |
| 07/23/2003 | CN1115160C Oral medicine for treating hyperosteogeny |
| 07/23/2003 | CN1115158C Health medicine for antisenescence |
| 07/23/2003 | CN1115157C Liver recovery decoction for treating liver disease and its prepn. method |
| 07/23/2003 | CN1115156C Antisenescence Chinese medicine |
| 07/23/2003 | CN1115154C Piles medicine |
| 07/22/2003 | US6597004 Powdered far-infrared radiator and method of making the same |
| 07/22/2003 | US6596698 Localized arterial transduction of RB2/pl30 via a viral vector at the time of angioplasty drastically reduces neointimal hyperplasia and prevents restenosis |
| 07/22/2003 | US6596694 Caloporoside derivatives, methods of their preparation and use |
| 07/22/2003 | US6596530 Lactobacillus for use in the generation of food product |
| 07/22/2003 | US6596529 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 07/22/2003 | US6596515 Insulin gene amplified from human genomic DNA by use of a pair of insulin primers and a K14 promoter gene amplified by use of a pair of K14 primers inserted together into pUChsneo |
| 07/22/2003 | US6596498 Bone stimulating factor |
| 07/22/2003 | US6596319 Such as various cancers, by administering low molecular weight compounds of following properties: extractable from bile of an animal, stimulates monocytes and macrophages, modulates tumor necrosis factor production, not endotoxin |
| 07/22/2003 | US6596310 Method of artificial insemination by timed release of sperm from capsules or solid beads |
| 07/22/2003 | US6596303 Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals |
| 07/22/2003 | US6596301 Lactobacillus helveticus fermented sour milk; ameliorating tension, depression fatigue and emotional derangement |
| 07/22/2003 | US6596282 Treatment of chronic viral infections with M. vaccae |
| 07/22/2003 | US6596275 Increasing release of PGE-2, IL-10 and/or IL-4; decreasing expression and secretion of IL-1, IL-12 and/or IFM gamma cytokines; decreasing prescence of CD80, CD86 and/or CD40 antigens; having polylysine-cDNA encoding cell nucleus |
| 07/22/2003 | US6596274 Dermal substitute in cutaneous lesions; repairing damaged connective tissue |
| 07/22/2003 | US6596270 Administering the adenoviral gene transfer vector (exogenous) encoding a gene product to a muscle and the vector is neutralized outside of the muscle by systemic neutralizing antibodies; using a chimeric coat protein for cell entry |
| 07/22/2003 | US6596269 Methods of treating chronic pain |
| 07/22/2003 | US6596268 Viruses for the treatment of cellular proliferative disorders |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057906A1 A new vector for genetically modifying non-human animals |
| 07/17/2003 | WO2003057892A2 Viruses with enhanced lytic potency |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057878A1 INDUCTION OF THE FORMATION OF INSULIN-PRODUCING CELLS VIA GENE TRANSFER OF PANCREATIC β-CELL-ASSOCIATED TRANSCRIPTIONAL FACTOR |
| 07/17/2003 | WO2003057865A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements |
| 07/17/2003 | WO2003057862A2 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | WO2003057853A2 Oxidative stress-resistant cell lines and methods of use thereof |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2003057714A2 A method of developing an anti-protein and regulation of a cellular function by administering an effective amount of the anti-protein |
| 07/17/2003 | WO2003057380A2 Compositions including ammonia oxidizing bacteria and methods of using same |
| 07/17/2003 | WO2003057229A1 Antiviral and antipyretic formulation and the preparation method thereof |
| 07/17/2003 | WO2003057157A2 A stable aqueous suspension |
| 07/17/2003 | WO2003056940A1 Nutritional functional food and yeast/lactic acid bacterium parallel fermentationproduct ah21 |
| 07/17/2003 | WO2003035838A3 Stem cells that transform to beating cardiomyocytes |
| 07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
| 07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 07/17/2003 | WO2002081646A3 Epitope sequences |
| 07/17/2003 | WO2002076285A3 Composition and methods fro the production of biological tissues and tissue constructs |
| 07/17/2003 | US20030134789 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 07/17/2003 | US20030134787 Engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in |
| 07/17/2003 | US20030134422 Stem cell maturation for all tissue lines |
| 07/17/2003 | US20030134419 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 07/17/2003 | US20030134418 Separating then enriching culture with nonparenchymal cells supplemented with nicotinamide; cell proliferation/detoxification |
| 07/17/2003 | US20030134415 Producing polyclonal autologous t-cells in the absence of exogenous cytokines; antiinflammatory agents; antitumor agents |
| 07/17/2003 | US20030134414 Ligating a peripheral nerve, then excising material rich in glial cells, providing a support matrix and inserting into spinal cords |
| 07/17/2003 | US20030134413 Culturing and differentiating early primitive ectoderm-like (EPL) tissues with subsequent recovery of pluripotent neurectodermal cells; gene therapy for nervous system disorders |
| 07/17/2003 | US20030134341 Th1 cell adoptive immunotherapy |
| 07/17/2003 | US20030133929 Draining blood from the animal, separating blood cells from plasma, contacting plasma with a solvent in which lipids are soluble, separating plasma to reintroduce it into the animal, separating dissolved lipids |
| 07/17/2003 | US20030133922 Sterilization of allogeneic human platelets to remove harmful bacteria and viruses, and oral feeding to patient with immune thrombocytopenic purpura; autoimmune disease |
| 07/17/2003 | US20030133921 Enterobacteria live or dead as active materials can absorbing the toxic chemical in body intestinal tracts, and accelerate excretion from body; detoxification |
| 07/17/2003 | US20030133918 Cell culturing, expressing a protein through the guanine nucleotide biosynthesis pathway, treating wound repair; wound healing agents |
| 07/17/2003 | US20030133914 Method for suppressing immune system response to transplanted tissue or cells |
| 07/17/2003 | US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes |
| 07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 07/17/2003 | US20030133875 Assay for screening candidate drug for the treatment of inflammatory diseases and methods for treating the same |
| 07/17/2003 | CA2473097A1 Compositions including ammonia oxidizing bacteria and methods of using same |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2469052A1 Transdifferentiation of pancreatic acinar cells |
| 07/16/2003 | EP1327688A1 Adenoviruses with enhanced lytic potency |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326968A1 Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells |
| 07/16/2003 | EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 07/16/2003 | EP1326893A2 Plasma fraction containing bikunin, method for the production thereof and use of the same |